409 related articles for article (PubMed ID: 33982266)
1. Clinical Pharmacokinetic and Pharmacodynamic Considerations in the Drug Treatment of Non-Tuberculous Mycobacteria in Cystic Fibrosis.
Burke A; Smith D; Coulter C; Bell SC; Thomson R; Roberts JA
Clin Pharmacokinet; 2021 Sep; 60(9):1081-1102. PubMed ID: 33982266
[TBL] [Abstract][Full Text] [Related]
2. Cystic Fibrosis-Related Nontuberculous Mycobacterial Pulmonary Disease.
Baird T; Bell S
Clin Chest Med; 2023 Dec; 44(4):847-860. PubMed ID: 37890921
[TBL] [Abstract][Full Text] [Related]
3. Clinical course and significance of nontuberculous mycobacteria and its subtypes in cystic fibrosis.
Eikani MS; Nugent M; Poursina A; Simpson P; Levy H
BMC Infect Dis; 2018 Jul; 18(1):311. PubMed ID: 29980189
[TBL] [Abstract][Full Text] [Related]
4. Nontuberculous mycobacterial infections in cystic fibrosis.
Martiniano SL; Nick JA
Clin Chest Med; 2015 Mar; 36(1):101-15. PubMed ID: 25676523
[TBL] [Abstract][Full Text] [Related]
5. [Mycobacterial lung disease in patients with cystic fibrosis--report of three cases].
Wyrostkiewicz D; Skorupa W; Jakubowska L; Zabost A; Kuś J
Pneumonol Alergol Pol; 2014; 82(6):561-7. PubMed ID: 25339567
[TBL] [Abstract][Full Text] [Related]
6. Nontuberculous Mycobacteria in Cystic Fibrosis.
Richards CJ; Olivier KN
Semin Respir Crit Care Med; 2019 Dec; 40(6):737-750. PubMed ID: 31659731
[TBL] [Abstract][Full Text] [Related]
7. Nontuberculous mycobacteria in cystic fibrosis: Updates and the path forward.
Martiniano SL; Davidson RM; Nick JA
Pediatr Pulmonol; 2017 Nov; 52(S48):S29-S36. PubMed ID: 28881094
[TBL] [Abstract][Full Text] [Related]
8. Incidence of nontuberculous mycobacteria infections among persons with cystic fibrosis in the United States (2010-2019).
Marshall JE; Mercaldo RA; Lipner EM; Prevots DR
BMC Infect Dis; 2023 Jul; 23(1):489. PubMed ID: 37488500
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and importance of non-tuberculous mycobacteria in adult patients with cystic fibrosis in a hospital in Madrid.
Fernández-Caso B; Vázquez R; Alarcón T; Girón R; López-Giménez MR; Domingo D
Enferm Infecc Microbiol Clin (Engl Ed); 2020; 38(7):323-326. PubMed ID: 31744623
[TBL] [Abstract][Full Text] [Related]
10. Specificity of Immunoglobulin Response to Nontuberculous Mycobacteria Infection in People with Cystic Fibrosis.
Malcolm KC; Wheeler EA; Calhoun K; Lenhart-Pendergrass PM; Rysavy N; Poch KR; Caceres SM; Saavedra MT; Nick JA
Microbiol Spectr; 2022 Aug; 10(4):e0187422. PubMed ID: 35863022
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology of nontuberculous mycobacterial infections and associated chronic macrolide use among persons with cystic fibrosis.
Binder AM; Adjemian J; Olivier KN; Prevots DR
Am J Respir Crit Care Med; 2013 Oct; 188(7):807-12. PubMed ID: 23927602
[TBL] [Abstract][Full Text] [Related]
12. Nontuberculous mycobacteria in cystic fibrosis and non-cystic fibrosis bronchiectasis.
Park IK; Olivier KN
Semin Respir Crit Care Med; 2015 Apr; 36(2):217-24. PubMed ID: 25826589
[TBL] [Abstract][Full Text] [Related]
13. IgA Serological Response for the Diagnosis of Mycobacterium abscessus Infections in Patients with Cystic Fibrosis.
Le Moigne V; Roux AL; Mahoudo H; Christien G; Ferroni A; Dumitrescu O; Lina G; Bouchara JP; Plésiat P; Gaillard JL; Canaan S; Héry-Arnaud G; Herrmann JL
Microbiol Spectr; 2022 Jun; 10(3):e0019222. PubMed ID: 35583329
[TBL] [Abstract][Full Text] [Related]
14. Nontuberculous Mycobacterial Infections in Cystic Fibrosis.
Martiniano SL; Nick JA; Daley CL
Clin Chest Med; 2022 Dec; 43(4):697-716. PubMed ID: 36344075
[TBL] [Abstract][Full Text] [Related]
15. Challenging scenarios in nontuberculous mycobacterial infection in cystic fibrosis.
Martiniano SL; Esther CR; Haworth CS; Kasperbauer SH; Zemanick ET; Caverly LJ
Pediatr Pulmonol; 2020 Feb; 55(2):521-525. PubMed ID: 31821718
[TBL] [Abstract][Full Text] [Related]
16. Nontuberculous Mycobacterial Infections in Cystic Fibrosis.
Martiniano SL; Nick JA; Daley CL
Thorac Surg Clin; 2019 Feb; 29(1):95-108. PubMed ID: 30454926
[TBL] [Abstract][Full Text] [Related]
17. Nontuberculous mycobacteria: the changing epidemiology and treatment challenges in cystic fibrosis.
Leung JM; Olivier KN
Curr Opin Pulm Med; 2013 Nov; 19(6):662-9. PubMed ID: 24048085
[TBL] [Abstract][Full Text] [Related]
18. Treating nontuberculous mycobacteria in children with cystic fibrosis: a multicentre retrospective study.
Saint GL; Thomas MF; Zainal Abidin N; Langley RJ; Brodlie M; McNamara P;
Arch Dis Child; 2022 May; 107(5):479-485. PubMed ID: 34740877
[TBL] [Abstract][Full Text] [Related]
19. Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosis.
Waters V; Ratjen F
Cochrane Database Syst Rev; 2020 Jun; 6(6):CD010004. PubMed ID: 32521055
[TBL] [Abstract][Full Text] [Related]
20. Deficient Complement Opsonization Impairs Mycobacterium avium Killing by Neutrophils in Cystic Fibrosis.
Lenhart-Pendergrass PM; Malcolm KC; Wheeler E; Rysavy NM; Poch K; Caceres S; Calhoun KM; Martiniano SL; Nick JA
Microbiol Spectr; 2023 Feb; 11(1):e0327922. PubMed ID: 36651756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
